The Effects of the Crohn's Disease Exclusion Diet on the Clinical Course of Inflammatory Bowel Diseases in Pediatric and Adult Populations
DOI:
https://doi.org/10.12775/QS.2026.54.70701Keywords
Crohn's disease, diet therapy, Crohn’s disease exclusion diet, inflammatory bowel disease, clinical remission, gut microbiotaAbstract
Introduction:
Crohn's disease is a chronic inflammatory condition of the gastrointestinal tract and a major subtype of inflammatory bowel disease (IBD). Its multifactorial etiology involves genetic, immunological, and environmental factors, among which diet plays a key role in modulating gut microbiota and intestinal barrier function.
Aim of the study:
This narrative review aims to evaluate the role of dietary interventions in Crohn's disease, with particular emphasis on the effectiveness of the Crohn's Disease Exclusion Diet (CDED) in inducing and maintaining remission.
Materials and methods:
A comprehensive literature review was conducted using Google Scholar and scientific databases. The analysis included randomized controlled trials, prospective and retrospective studies, and experimental research focusing on the impact of dietary interventions, particularly CDED, on clinical outcomes in patients with Crohn's disease.
Results:
The reviewed studies indicate that CDED, especially when combined with partial enteral nutrition (PEN), is effective in inducing clinical remission and reducing inflammatory markers. Compared to exclusive enteral nutrition (EEN), CDED demonstrates better patient adherence and tolerability. Additionally, the diet positively influences gut microbiota composition and intestinal barrier integrity.
Conclusions:
CDED appears to be a promising dietary strategy in the management of Crohn's disease. However, despite encouraging results, further large-scale and long-term studies are required to confirm its effectiveness and establish its role in standard treatment guidelines.
References
Levine A, Wine E, Assa A, et al. Crohn's disease exclusion diet plus partial enteral nutrition induces sustained remission in a randomized controlled trial. Gastroenterology. 2019;157(2):440-450. doi:10.1053/j.gastro.2019.04.021
Szczebułek M, Pomorska K, Korzeniowska K, Jurkowska G, Rydzewska G. Effectiveness of Crohn's disease exclusion diet for induction of remission in Crohn's disease adult patients. Nutrients. 2021;13(11):4112. doi:10.3390/nu13114112
Niseteo T, Dugum M, Pavić T. Dietary interventions in inflammatory bowel disease: focus on Crohn's disease exclusion diet. Nutr Clin Pract. 2022. doi:10.1002/ncp.10864
Zhang JL, Wang XY, Guo XY, et al. The role of diet in inflammatory bowel disease: current evidence and future directions. BMC Gastroenterol. 2024;24:45. doi:10.1186/s12876-024-03045-2
Lewis JD, Abreu MT. Diet as a trigger or therapy for inflammatory bowel diseases. Gastroenterology. 2017;152(2):398-414. doi:10.1053/j.gastro.2016.10.019
Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011;106(4):563-573. doi:10.1038/ajg.2011.44
Khalili H, Chan SSM, Lochhead P, Ananthakrishnan AN, Hart AR, Chan AT. The role of diet in the aetiopathogenesis of inflammatory bowel disease. Nat Rev Gastroenterol Hepatol. 2018;15(9):525-535. doi:10.1038/s41575-018-0022-9
Sokol H, Seksik P, Landman C. The role of the gut microbiota in inflammatory bowel disease. Therap Adv Gastroenterol. 2017;10(12):957-968. doi:10.1177/1756283X17733448
Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390(10114):2769-2778. doi:10.1016/S0140-6736(17)32448-0
Vavricka SR, Schoepfer A, Scharl M, et al. Extraintestinal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(8):1982-1992. doi:10.1097/MIB.0000000000000392
Rieder F, Zimmermann EM, Remzi FH, Sandborn WJ. Crohn's disease complicated by strictures: a systematic review. Gut. 2016;62(7):1072-1084. doi:10.1136/gutjnl-2012-303228
Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010;362(15):1383-1395. doi:10.1056/NEJMoa0904492
Feagan BG, Sandborn WJ, Gasink C, et al. Ustekinumab as induction and maintenance therapy for Crohn's disease. N Engl J Med. 2016;375(20):1946-1960. doi:10.1056/NEJMoa1602773
Torres J, Mehandru S, Colombel JF, Peyrin-Biroulet L. Crohn's disease. Lancet. 2017;389(10080):1741-1755. doi:10.1016/S0140-6736(16)31711-1
Sigall Boneh R, Sarbagili Shabat C, Yanai H, et al. Dietary therapy with the Crohn's Disease Exclusion Diet is a successful strategy for induction of remission in children and adults failing biological therapy. J Crohns Colitis. 2017;11(10):1205-1212. doi:10.1093/ecco-jcc/jjx071
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Agnieszka Woźniacka, Agnieszka Piechowicz , Sylwia Bryksy, Hanna Tymchenko, Aleksandra Marciszewska, Martyna Świątecka, Jakub Kaźmierczyk, Jakub Jopek, Michał Popczyk, Ewa Buczkowska

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 15
Number of citations: 0